BP
Bryn Pharma, Inc.
SEC filingOther Health Care · Lebanon, NJ
Amount raised$4.7Msold at filing
Total offering$4.7M
Investors in the raise105count reported to the SEC
FiledAug 14, 2025first sale Apr 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Anne WhitakerDirector
Michael KasetaDirector
Jeff HartnessDirector
Steven HartmanDirector
Joshua ZielExecutive Officer
Michelle LobelDirector
Steven KillmeyerExecutive Officer
Marc RapaportDirector
Lisa LichtDirector
Sandra LoreauxDirector
James BornemanExecutive Officer
Kate Soper DiazDirector
Executive officers, directors and promoters as listed on the Form D.